SELLAS Life Sciences Group, Inc. (SLS) Price
SELLAS Life Sciences Group, Inc.
SLS
$2.04
-$0.08 (-3.77%)
Au cours de la dernière année
Volume (24 h)
$5.677M
Offre en circulation
142.4M
Capitalisation boursière
$286.3M
À propos du SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.
Télécharger le
Application mobile Gemini
Parrainez vos amis, gagnez des cryptomonnaies.
Invitez vos amis sur Gemini et gagnez tous les deux 50 $ en cryptomonnaie votre filleul tradent 100 $ au cours des 30 premiers jours.
Jetons populaires
Gemini ActiveTrader®
Trader SELLAS Life Sciences Group, Inc. sur la plateforme conçue et développée pour les traders
Jetons populaires
À propos du SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.
Articles Cryptopedia sur SELLAS Life Sciences Group, Inc.
Données récentes sur le cours du SELLAS Life Sciences Group, Inc. (SLS)
Le prix de SELLAS Life Sciences Group, Inc. est de a baissé par -3.77% au cours des 24 dernières heures. Le prix actuel est de $2.04 par SELLAS Life Sciences Group, Inc.. L'offre en circulation actuelle est de 286.3M SLS.
Dernière mise à jour : 2025/12/12 23:56 (UTC)